Addex Reports Q1 2023 Financial Results and Provides Corporate Update
ADX71149 Phase 2 epilepsy clinical study’s independent interim review committee (“IRC”) recommends continuing study CHF…
ADX71149 Phase 2 epilepsy clinical study’s independent interim review committee (“IRC”) recommends continuing study CHF…
TOKYO, May 11, 2023 – (JCN Newswire) – Fujitsu today revealed that it leveraged AI…
Music label to establish a borderless community for web3 enthusiasts, musicians and artists to connect,…
SINGAPORE, May 11, 2023 – (ACN Newswire) – Lumen Technologies (NYSE: LUMN), a leading global…
Regula emerged as a winner in two categories of the 11th Annual Global InfoSec Awards…
The contract is scheduled to last up to 10 years and will provide the latest…
ISTANBUL & RICHARDSON, Texas–(BUSINESS WIRE)–#OpenRAN–Mavenir, the Network Software Provider building the future of networks with…
Strong Q1’23 performance. Our pivot towards enhancing the focus and efficiency of our business paid…
Toyota City, Japan, May 11, 2023 – (JCN Newswire) – The Toyota Mobility Foundation (TMF)…
Mobile News: Sony releases a new flagship smartphone for mobile content creators and enthusiasts with…
PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX and Nasdaq: VQS), a global…
Lesion Growth from Baseline Lesion Growth from Baseline In 18-month interim data from ongoing 2-year,…
Toronto, Ontario–(Newsfile Corp. – May 10, 2023) – RIWI Corp. (TSXV: RIWI) (OTC Pink: RWCRF)…
BGSF Go-to-Market Re-branding Project for All Business Units Well Underway PLANO, Texas–(BUSINESS WIRE)–BGSF, Inc. (NYSE:…
SHARON, Pa.–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider,…
THE WOODLANDS, Texas–(BUSINESS WIRE)–Excelerate Energy, Inc. (NYSE: EE) (the “Company” or “Excelerate”) today reported its…
May 2023 Monthly Dividend of $0.16 Per Share of Common Stock RMBS Portfolio Characteristics as…
Montrouge, France, May 10, 2023 DBV Technologies Announces New England Journal of Medicine Publication of…
CTIM-76 IND filing on track for Q1 2024 Preclinical data on CLDN6 bispecific antibody CTIM-76…
Sotagliflozin reduced the risk of cardiovascular death and heart failure readmissions in patients hospitalized for…